Insufficient scRNA-seq data for expression of IFNL1 at single-cell level.
Insufficient scRNA-seq data for expression of IFNL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 85% | 6.50 | 205 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 64% | 3.39 | 591 / 929 | 0% | 0 | 0 / 0 |
lung | 44% | 1.10 | 257 / 578 | 9% | 0.27 | 103 / 1155 |
ovary | 23% | 0.34 | 41 / 180 | 28% | 0.82 | 119 / 430 |
pancreas | 34% | 0.76 | 110 / 328 | 7% | 0.21 | 13 / 178 |
bladder | 33% | 0.48 | 7 / 21 | 7% | 0.17 | 37 / 504 |
uterus | 28% | 0.54 | 48 / 170 | 12% | 0.34 | 53 / 459 |
esophagus | 24% | 0.49 | 353 / 1445 | 13% | 1.31 | 24 / 183 |
intestine | 31% | 0.78 | 299 / 966 | 6% | 0.14 | 33 / 527 |
stomach | 25% | 0.52 | 90 / 359 | 12% | 0.33 | 34 / 286 |
thymus | 34% | 0.86 | 219 / 653 | 2% | 0.03 | 10 / 605 |
breast | 20% | 0.35 | 91 / 459 | 15% | 0.51 | 163 / 1118 |
kidney | 33% | 0.69 | 29 / 89 | 1% | 0.04 | 11 / 901 |
liver | 31% | 0.75 | 69 / 226 | 0% | 0.00 | 1 / 406 |
brain | 30% | 0.59 | 796 / 2642 | 0% | 0 | 0 / 705 |
skin | 29% | 0.66 | 520 / 1809 | 1% | 0.02 | 5 / 472 |
prostate | 29% | 0.62 | 71 / 245 | 1% | 0.02 | 4 / 502 |
adipose | 25% | 0.51 | 306 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 20% | 0.37 | 271 / 1335 | 0% | 0 | 0 / 0 |
muscle | 18% | 0.24 | 143 / 803 | 0% | 0 | 0 / 0 |
heart | 14% | 0.24 | 120 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.29 | 4 / 29 |
adrenal gland | 13% | 0.26 | 34 / 258 | 0% | 0.01 | 1 / 230 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.43 | 6 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0045581 | Biological process | negative regulation of T cell differentiation |
GO_0045087 | Biological process | innate immune response |
GO_0051607 | Biological process | defense response to virus |
GO_0045345 | Biological process | positive regulation of MHC class I biosynthetic process |
GO_0002829 | Biological process | negative regulation of type 2 immune response |
GO_0098586 | Biological process | cellular response to virus |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0032696 | Biological process | negative regulation of interleukin-13 production |
GO_0043381 | Biological process | negative regulation of memory T cell differentiation |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0050778 | Biological process | positive regulation of immune response |
GO_0032714 | Biological process | negative regulation of interleukin-5 production |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0038196 | Biological process | type III interferon-mediated signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0032002 | Cellular component | interleukin-28 receptor complex |
GO_0032003 | Molecular function | interleukin-28 receptor binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IFNL1 |
Protein name | Interferon lambda-1 (IFN-lambda-1) (Cytokine Zcyto21) (Interleukin-29) (IL-29) |
Synonyms | ZCYTO21 IL29 |
Description | FUNCTION: Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN-stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type-selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression. |
Accessions | ENST00000709027.1 Q8IU54 ENST00000333625.3 |